Pathstone Holdings
LMAT icon

Pathstone Holdings’s LeMaitre Vascular LMAT Stock Holding History

Pathstone Holdings’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Sell
3,766
-65
-2% -$6.66K ﹤0.01% 2029
2026
Q1 		$418K Sell
3,831
-86
-2% -$8.2K ﹤0.01% 1829
2025
Q4 		$318K Sell
3,917
-8
-0.2% -$689 ﹤0.01% 1937
2025
Q3 		$344K Buy
3,925
+344
+10% +$30.7K ﹤0.01% 1966
2025
Q2 		$297K Sell
3,581
-1,179
-25% -$98.5K ﹤0.01% 1928
2025
Q1 		$400K Buy
4,760
+61
+1% +$5.67K ﹤0.01% 1815
2024
Q4 		$433K Sell
4,699
-277
-6% -$26.6K ﹤0.01% 1789
2024
Q3 		$462K Buy
4,976
+24
+0.5% +$2.08K ﹤0.01% 1765
2024
Q2 		$407K Buy
4,952
+8
+0.2% +$588 ﹤0.01% 1796
2024
Q1 		$328K Sell
4,944
-327
-6% -$20.2K ﹤0.01% 1891
2023
Q4 		$299K Buy
+5,271
New +$276K ﹤0.01% 1829

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pathstone Holdings's LMAT Position: Q2 2026 in Review

Pathstone Holdings reduced its LeMaitre Vascular (LMAT) stake by 1.7% in Q2 2026, selling an estimated $6.66K and leaving 3,766 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #2029.

Pathstone Holdings first reported a position in LMAT in Q4 2023 and has held it in 11 quarters since. The position peaked at $462K in Q3 2024. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Pathstone Holdings held 3,766 shares of LeMaitre Vascular worth $361K as of Q2 2026.
  • Pathstone Holdings sold 65 LeMaitre Vascular shares in Q2 2026, an estimated $6.66K.
  • LeMaitre Vascular made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2029 holding.
  • Pathstone Holdings first reported a position in LeMaitre Vascular in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's LeMaitre Vascular position peaked at $462K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.